About
HPV-induced cancer treatments
Areas of Focus
Categories
Biologics & BiopharmaceuticalBoston & New England
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
183
By Phase
PHASE1/PHASE2: 1PHASE1: 1
By Status
ACTIVE_NOT_RECRUITING: 1COMPLETED: 1AVAILABLE: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT05726864Lead Sponsor
A Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors
PHASE1/PHASE2Active, not recruiting
158 participants
Started: Apr 14, 2023 · Completed: Nov 30, 2026
NCT04853017Lead Sponsor
A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors
PHASE1Completed
25 participants
Started: Oct 4, 2021 · Completed: Sep 24, 2024
NCT07083479Lead Sponsor
Expanded Access Protocol of ELI-002-102 in Subjects With KRAS/NRAS Mutated Pancreatic Ductal Adenocarcinoma
N/AAVAILABLE
Locations (1)
Headquarters
Boston, MA, United States
Map
Loading map...